CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 6 No. 8
 

Increased Numbers of Nevi Can Predict Risk of Melanoma

August 1, 1997

BETHESDA, Md--Increased numbers of small nevi, large nondysplastic nevi, and clinically dysplastic nevi strongly increase a person's risk of developing melanoma--a finding with major preventive implications, according to investigators in a large, case-control study.

"The clinical implications are that a clinician or health care provider can establish the risk of melanoma by skin examination alone," said Margaret A. Tucker, MD, of the National Cancer Institute's Genetic Epidemiologic Branch. She presented data from the study at the General Motors Cancer Research Foundation's annual scientific conference held at the National Institutes of Health.

Some 40,300 new melanoma cases will be diagnosed and 7,300 melanoma deaths will occur in the United States during 1997. The incidence of melanoma has continued to rise "dramatically since the 1930s," Dr. Tucker said.

The reason remains uncertain, but studies have linked increased sun exposure and the presence of nevi to the disease. However, few of these epidemiologic studies successfully evaluated the relative contribution of small, large, and dysplastic nevi.

Researchers from NCI, the University of California, San Francisco, and the University of Pennsylvania launched a major effort to sort out the issue. They enrolled 716 consecutive newly diagnosed melanoma patients at the two medical schools during 1991 and 1992. These patients were matched with 1,014 controls randomly selected from outpatient clinics and matched for age, sex, race, and geographic distribution.

All study participants were interviewed and received complete skin examinations, including photographs of most atypical nevi and a biopsy of the most atypical nevus, if they were willing. The criteria for a dysplastic nevi included a size greater than 5 mm with a flat component and at least two of the following characteristics: variable pigmentation, irregular outline, and indistinct borders.

Small Nevi Increase Risk Twofold

The researchers found that in patients without dysplastic nevi, increased numbers of small nevi raised the risk of melanoma about twofold; increased numbers of both small and large nondysplastic nevi raised the risk fourfold.

A single dysplastic nevus increased the melanoma risk twofold. Ten or more dysplastic nevi shot the risk up 12-fold. Dr. Tucker noted that dysplastic nevi occur in about 10% of the US population. The study also showed that congenital nevi did not confer an increased risk, while freckling raised the risk twofold.

After adjusting for dysplastic nevi, total nevi, age, sex, freckling, and skin type, the team found that melanoma risk increased with the total number of sunburns. One to three sunburns increased a person's risk 40%; 10 or more burns nearly doubled the risk. "The risks were highest in those with both multiple dysplastic nevi and sunburns, a more than 20-fold increase," Dr. Tucker said.

To the researchers' surprise, however, sunburns prior to age 13 did not increase risk, a finding contrary to some other studies. "We found a small risk associated with early sun exposure, but it did not reach statistical significance," she said.

Living in the tropics, using sunbeds or tanning booths, or working outdoors did not increase the risk of melanoma among the study participants.

"There are many people with an increased number of common nevi who are at a two- to fourfold increased risk of melanoma, and people with unusual nevi are at roughly a 10-fold increased risk," Dr. Tucker said.

Thus, she noted, a subset of patients can be identified who could benefit from surveillance, with early biopsy of dysplastic nevi, and intervention (warnings to stay out of the sun).

Said Dr. Tucker: "We know from our studies of familial melanoma that once we get people with this inherited predisposition out of the sun, their risk of developing melanoma drops substantially after five years."

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy